Hemoglobin or Epo Dose: Which Poses Heart Risk?
George Bakris talked to Peter McCullough about the role of hemoglobin and erythropoietin in cardiovascular events in patients with chronic kidney disease.
Source: Medscape Nephrology Podcast - Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Heart | Podcasts | Urology & Nephrology